Peroperative clinical study of intravenous iron sucrose in patients with radical gastric cancer

ZHU Wenwen; LI Ying; ZHOU Xiaoyu

doi:10.3969/j.issn.1674-4136.2023.06.009

Abstract：Objective To investigate the effect of intravenous iron sucrose on perioperative transfusion and clinical condition in patients with radical gastric cancer.Methods A total of 186 anemia patients were treated in the First Affiliated Hospital of Nanjing Medical University from January 2022 to June 2023.According to their anemia status,they were divided into preoperative severe anemia group,preoperative moderate anemia group,postoperative anemia group and postoperative no anemia group.The two preoperative anemia groups were divided into A using iron sucrose and B without using iron sucrose according to intravenous iron sucrose injection status in patients.Results The difference between the total amount of perioperative red blood cell transfusion was significant in group A and Group B in the preoperative severe anemia group(P=0.002),and it was not significant in the preoperative moderate anemia group(P=0.495).There's no difference between the postoperative hemoglobin of 24 hours,7days and 30days and hospital days in group A and Group B in the preoperative severe anemia group(P＞0.05).Postoperative anemia and no anemia were not associated with iron sucrose infusion(P=0.655).Conclusions Intravenous iron sucrose can significantly reduce the perioperative red blood cell transfusion in patients with severe anemia,and don't reduce the postoperative hemoglobin of 24 hours,7days and 30days,don't extend the hospital days.